We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

MedImmune Targets 5 PDL Patents In Licensing Spat

Law360 (December 18, 2008, 12:00 AM EST) -- MedImmune LLC is seeking the invalidation of five patents owned by PDL BioPharma Inc. as part of a licensing fight over a respiratory drug for infants and a related product that...
To view the full article, register now.